AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01614-06v1
51/8/2855    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lartigue, M.-F.
Right arrow Articles by Nordmann, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lartigue, M.-F.
Right arrow Articles by Nordmann, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2007, p. 2855-2860, Vol. 51, No. 8
0066-4804/07/$08.00+0     doi:10.1128/AAC.01614-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Extended-Spectrum ß-Lactamases of the CTX-M Type Now in Switzerland{triangledown}

Marie-Frédérique Lartigue,1,{dagger} Catherine Zinsius,1 Aline Wenger,2 Jacques Bille,2 Laurent Poirel,1 and Patrice Nordmann1*

Service de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, Université Paris Sud, 94275 K.-Bicêtre, France,1 Institut de Microbiologie, Centre Hospitalier Universitaire Vaudois, CH1011 Lausanne, Switzerland2

Received 27 December 2006/ Returned for modification 2 February 2007/ Accepted 9 April 2007

The epidemiology of clavulanic acid-inhibited extended-spectrum ß-lactamases (ESBLs) was investigated among infection-associated enterobacterial isolates at the University Hospital in Lausanne, Switzerland, from January 2004 to June 2005. Out of 57 nonrepetitive ESBL producers (prevalence rate of 0.7%), 45 produced CTX-M-like ESBLs. CTX-M enzymes were mostly from clonally nonrelated Escherichia coli isolates, from urinary infections and community-acquired infections. Pediatric patients (20 out of 57) accounted for a large number of CTX-M producers. CTX-M-15 was the most frequent CTX-M-type enzyme. The plasmid-located blaCTX-M genes were associated with either ISEcp1 or ISCR1 insertion sequences. This study is the first published report of CTX-M-type ß-lactamases in Switzerland.

* Corresponding author. Mailing address: Service de Bactériologie-Virologie, Hôpital de Bicêtre, 78 rue du Général Leclerc, 94275 K.-Bicêtre, France. Phone: 33-1-45-21-36-32. Fax: 33-1-45-21-63-40. E-mail: nordmann.patrice{at}bct.aphp.fr

{triangledown} Published ahead of print on 30 April 2007.

{dagger} Present address: Service de Bactériologie-Hygiène, CHRU Trousseau, UFR Médecine, Université François-Rabelais de Tours, 37000 Tours Cedex, France.

Antimicrobial Agents and Chemotherapy, August 2007, p. 2855-2860, Vol. 51, No. 8
0066-4804/07/$08.00+0     doi:10.1128/AAC.01614-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.